Reduced exercise capacity in systemic sclerosis patients without pulmonary involvement
- 1 January 2007
- journal article
- research article
- Published by Taylor & Francis in Scandinavian Journal of Rheumatology
- Vol. 36 (6) , 458-461
- https://doi.org/10.1080/03009740701605889
Abstract
To evaluate the exercise capacity of women with systemic sclerosis (SSc) without pulmonary involvement using a cardiopulmonary stress test. Thirteen consecutive female SSc patients [mean age 40.8+/-14 years, mean body mass index (BMI) 25.5+/-3.7 kg/m2] without pulmonary and cardiac involvement and 13 healthy sedentary female controls (mean age 41.6+/-9.1 years, mean BMI 23.7+/-3.8 kg/m2) matched by age and BMI underwent a maximum cardiopulmonary stress test (Bruce protocol). The following parameters were analysed: peak oxygen uptake (VO2peak), anaerobic threshold (AT), respiratory compensation point (RCP) and metabolic equivalent (MET) of the VO2peak. Comparisons between groups were analysed using the Student t-test. Forced vital capacity (FVC; 92.2+/-14.2% predicted) and carbon monoxide diffusion lung capacity (DL CO; 85.8+/-5.8% predicted) were within the normal range in SSc patients. VO2peak of SSc patients was significantly reduced in comparison to the control group (19.8+/-4.6 vs. 23.7+/-4.5 mL/kg/min, p = 0.04). SSc patients also had a significant reduction in MET at peak exercise (5.6+/-1.3 vs. 6.7+/-1.3 MET, p = 0.04) and a significant shorter time interval between AT and RCP compared to the control group (112.6+/-95.6 vs. 164.0+/-65.3 s, p = 0.03). SSc patients without pulmonary impairment have reduced exercise capacity. Abnormal vascular response to exercise may account for this finding, as the vascular system is one of the major target organs in this pathological condition.Keywords
This publication has 14 references indexed in Scilit:
- Submaximal exercise testing in the assessment of interstitial lung disease secondary to systemic sclerosis: reproducibility and correlations of the 6-min walk testAnnals of the Rheumatic Diseases, 2007
- Reduced Exercise Capacity and Stress-Induced Pulmonary Hypertension in Patients With SclerodermaChest, 2006
- Hormone replacement therapy may prevent the development of isolated pulmonary hypertension in patients with systemic sclerosis and limited cutaneous involvementScandinavian Journal of Rheumatology, 2006
- Systemic sclerosis and bone loss: the role of the disease and body compositionScandinavian Journal of Rheumatology, 2006
- Pulmonary hypertension is associated with impaired exercise performance in patients with systemic sclerosisScandinavian Journal of Rheumatology, 2000
- Cardiorespiratory Responses to Incremental Exercise in Patients With Systemic SclerosisChest, 1996
- Failure of the circulatory system limits exercise performance in patients with systemic sclerosisThe American Journal of Medicine, 1993
- Optimizing the exercise protocol for cardiopulmonary assessmentJournal of Applied Physiology, 1983
- Factors limiting exercise performance in progressive systemic sclerosisSeminars in Arthritis and Rheumatism, 1983
- Preliminary criteria for the classification of systemic sclerosis (scleroderma)Arthritis & Rheumatism, 1980